Literature DB >> 4717916

The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide.

M C Berenbaum, W A Cope, J A Double.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4717916      PMCID: PMC1553799     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  28 in total

1.  PROLONGATION OF HOMOGRAFT SURVIVAL IN MICE WITH SINGLE DOSES OF CYCLOPHOSPHAMIDE.

Authors:  M C BERENBAUM; I N BROWN
Journal:  Nature       Date:  1963-10-05       Impact factor: 49.962

2.  Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate.

Authors:  J AXELROD; J REICHENTHAL; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030

3.  Cyclophosphamide in lupus nephritis: a controlled trial.

Authors:  A D Steinberg; H B Kaltreider; P J Staples; E J Goetzl; N Talal; J L Decker
Journal:  Ann Intern Med       Date:  1971-08       Impact factor: 25.391

4.  Activation of cyclophosphamide in man and animals.

Authors:  N Brock; R Gross; H J Hohorst; H O Klein; B Schneider
Journal:  Cancer       Date:  1971-06       Impact factor: 6.860

5.  The effect of supralethal amethopterin and folinic acid rescue on mouse skin allograft survival.

Authors:  W M Abbott; A P Monaco; P S Russell
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

6.  Effect of microsomal enzyme modifiers on toxicity and therapeutic activity of cyclophosphamide in mice.

Authors:  L G Hart; R H Adamson
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-08

7.  Effect of chloramphenicol on the metabolism and lethality of cyclophosphamide in rats.

Authors:  R L Dixon
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

8.  Factors determining cell killing by chemotherapeutic agents in vivo. I. Cyclophosphamide.

Authors:  L M van Putten; P Lelieveld
Journal:  Eur J Cancer       Date:  1970-08       Impact factor: 9.162

9.  Immunosuppressive agents: generation and consequences of differing dose-response curves.

Authors:  M C Berenbaum
Journal:  Proc R Soc Med       Date:  1972-03

10.  Cyclophosphamide inhibition of experimental allergic encephalomyelitis in Wistar rats.

Authors:  P Y Paterson; M A Hanson; E W Gerner
Journal:  Proc Soc Exp Biol Med       Date:  1967-03
View more
  6 in total

Review 1.  The pharmacological and immunological basis for the use of immunosuppressive drugs.

Authors:  J F Bach
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  ICP0 is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses.

Authors:  J E Balow; J E Parrillo; A S Fauci
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

Review 4.  Synergy, additivism and antagonism in immunosuppression. A critical review.

Authors:  M C Berenbaum
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

5.  Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo.

Authors:  W P Halford; P A Schaffer
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.

Authors:  J W Babbage; M C Berenbaum
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.